Clinical trials using CIK cells with tumor entity and number of patients
Tumor entity |
Reference |
Phase |
Total number of patients treated with CIK cells |
---|---|---|---|
Hepatocellular carcinoma | M. Shi et al., 2004 | na | 13 |
Olioso et al., 2009 | pilot | 1 | |
Hui, Qiang, Jian, Ti, & Da-Lu, 2009 | na | 84 | |
C. Pan et al., 2010 | na | 42 | |
Hao et al., 2010 | na | 72 | |
J. Yu et al., 2011 | na | 2 | |
Niu et al., 2011 | na | 1 | |
P. Zhou et al., 2011 | I | 10 | |
Qiu et al., 2011 | na | 9 | |
Jinying Zhang et al., 2012 | retrospective | 2 | |
K. Pan et al., 2013 | retrospective | 204 | |
X. Yu et al., 2014 | II | 66 | |
Z. Zhang et al., 2015 | retrospective | 2 | |
Lee et al., 2015 | III | 114 | |
Y. Liu et al., 2016 | retrospective | 3 | |
Jian Zhang et al., 2018 | retrospective | 20 | |
C.-L. Chen et al., 2018 | I | 9 | |
Z. Zhou, Qin, Weng, & Ni, 2019 | retrospective | 35 | |
Yoon et al., 2019 | IV | 59 | |
C. Li et al., 2019 | na | 11 | |
Renal cell carcinoma |
Schmidt-Wolf et al., 1999 | I | 1 |
Olioso et al., 2009 | pilot | 5 | |
Su et al., 2010 | na | 16 | |
Jinying Zhang et al., 2012 | na | 10 | |
Zhan et al., 2012 | na | 46 | |
L. Liu et al., 2012 | na | 74 | |
Y. Zhang et al., 2013 | na | 10 | |
Z. Wang et al., 2014 | na | 29 | |
D. Wang et al., 2014 | na | 28 | |
X. Zhao et al., 2015 | na | 61 | |
Zheng et al., 2015 | na | 154 | |
Hong, Na-na, & Xin-hua, 2016 | na | 20 | |
C.-L. Chen et al., 2018 | I | 8 | |
Mai et al., 2018 | retrospective | 19 | |
Z. Wang et al., 2018 | na | 1 | |
C. Li et al., 2019 | na | 6 | |
Acute lymphoblastic leukemia | Introna et al., 2007 | I | 1 |
Laport et al., 2011 | na | 2 | |
Y. Linn et al., 2012 | I / II | 3 | |
Y. Luo et al., 2016 | I | 2 | |
Introna et al., 2017 | II a | na | |
Acute myelogenous leukemia | Introna et al., 2007 | I | 4 |
Introna et al., 2010 | na | 4 | |
Laport et al., 2011 | na | 3 | |
B. Yang et al., 2012 | pilot | 1 | |
Y. Linn et al., 2012 | I / II | 8 | |
Dong et al., 2012 | na | 21 | |
Y.-C. Linn et al., 2012 | I / II | 13 | |
Y. Wang et al., 2013 | na | 2 | |
Y. Luo et al., 2016 | I | 4 | |
Introna et al., 2017 | II a | na | |
Narayan et al., 2019 | II | 12 | |
Chronic lymphoblastic leukemia | Laport et al., 2011 | na | 2 |
Chronic myelogenous leukemia | Introna et al., 2007 | I | 1 |
B. Yang et al., 2012 | pilot | 3 | |
Y. Linn et al., 2012 | I / II | 1 | |
Y.-C. Linn et al., 2012 | I / II | 11 | |
Y. Luo et al., 2016 | I | 3 | |
Lymphoma | Schmidt-Wolf et al., 1999 | I | 2 |
Leemhuis, Wells, Scheffold, Edinger, & Negrin, 2005 | I | 9 | |
Introna et al., 2007 | I | 3 | |
Olioso et al., 2009 | pilot | 6 | |
Guo et al., 2011 | na | 8 | |
J. Yu et al., 2011 | na | 1 | |
Laport et al., 2011 | na | 6 | |
Y. Linn et al., 2012 | I / II | 4 | |
Jinying Zhang et al., 2012 | na | 1 | |
B. Yang et al., 2012 | pilot | 9 | |
Lu et al., 2012 | na | 9 | |
Qiu et al., 2016 | na | 14 | |
Y. Luo et al., 2016 | I | 4 | |
F. Chen et al., 2017 | na | 3 | |
Introna et al., 2017 | II a | na | |
Pfeffermann et al., 2018 | na | 1 | |
Bladder cancer | Jinying Zhang et al., 2012 | na | 1 |
C.-L. Chen et al., 2018 | I | 2 | |
Breast cancer | Niu et al., 2011 | na | 1 |
Jinying Zhang et al., 2012 | na | 1 | |
K. Pan et al., 2014 | retrospective | 45 | |
Ren et al., 2013 | na | 87 | |
Hong et al., 2016 | na | 9 | |
F. Chen et al., 2017 | na | 8 | |
C.-L. Chen et al., 2018 | na | 1 | |
C.-L. Chen et al., 2018 | na | 4 | |
Cervival cancer | Niu et al., 2011 | na | 1 |
N. Li et al., 2019 | na | 44 | |
Colorectal cancer | Niu et al., 2011 | na | 2 |
Jinying Zhang et al., 2012 | na | 4 | |
Y. Zhu et al., 2013 | retrospective | 21 | |
H. Zhu et al., 2014 | na | 100 | |
Gao et al., 2014 | na | na | |
Jinying Zhang et al., 2014 | na | 30 | |
Z. Zhang et al., 2015 | retrospective | 5 | |
Lin, Song, Chuo, Zhang, & Zhao, 2016 | prospective | 134 | |
H. Zhao et al., 2016 | II | 61 | |
Y. Liu et al., 2016 | retrospective | 18 | |
C. Zhang et al., 2017 | na | 3 | |
Xie et al., 2017 | retrospective | 71 | |
C.-L. Chen et al., 2018 | I | 6 | |
C. Li et al., 2019 | na | 12 | |
C.-L. Chen et al., 2018 | I | 6 | |
Esophagus cancer | Z. Zhang et al., 2015 | retrospective | 1 |
Y. Liu et al., 2016 | retrospective | 7 | |
C. Zhang et al., 2017 | na | 1 | |
Gallbladder cancer | Niu et al., 2011 | na | 1 |
Y. Liu et al., 2016 | retrospective | 4 | |
Gastric cancer | J. Jiang et al., 2006 | na | 32 |
J.-T. Jiang et al., 2010 | na | 75 | |
J. Yu et al., 2011 | na | 2 | |
Jinying Zhang et al., 2012 | na | 6 | |
L. Shi et al., 2012 | na | 74 | |
H. Liu, Song, Yang, & Zhang, 2013 | na | 51 | |
H. Zhao et al., 2013 | retrospective | 53 | |
Gao et al., 2014 | na | na | |
Z. Zhang et al., 2015 | retrospective | 1 | |
Cui et al., 2015 | pilot | 30 | |
Y. Liu et al., 2016 | retrospective | 14 | |
Xu et al., 2016 | II | 16 | |
Mu et al., 2016 | na | 13 | |
Hong et al., 2016 | na | 6 | |
Y. Chen et al., 2016 | retrospective | 95 | |
C. Li et al., 2019 | na | 19 | |
Qiao et al., 2019 | prospective | 30 | |
Glioblastoma | Kong et al., 2017 | III | 91 |
F. Chen et al., 2017 | na | 1 | |
Lung cancer | Wu, Jiang, Shi, & Xu, 2008 | prospective | 29 |
Hui Li et al., 2009 | na | 42 | |
J. Yu et al., 2011 | na | 9 | |
Zhong, Teng, Han, & Zhong, 2011 | na | 14 | |
Niu et al., 2011 | na | 8 | |
S. B. Shi, Ma, Li, & Tang, 2012 | na | 30 | |
Jinying Zhang et al., 2012 | na | 3 | |
R. Li et al., 2012 | II | 87 | |
L. Yang et al., 2013 | na | 61 | |
Jin et al., 2014 | na | 411 | |
Zhong, Han, & Zhong, 2014 | prospective | 60 | |
J. Zhang et al., 2015 | retrospective | 60 | |
Z. Zhang et al., 2015 | retrospective | 1 | |
P. Zhao et al., 2015 | na | 25 | |
H. Luo et al., 2016 | retrospective | 70 | |
Hong et al., 2016 | na | 10 | |
Y. Liu et al., 2016 | retrospective | 6 | |
L. Zhang et al., 2016 | na | 21 | |
Gu et al., 2017 | na | 32 | |
C. Zhang et al., 2017 | na | 4 | |
F. Chen et al., 2017 | na | 12 | |
C. Zhang et al., 2017 | na | 4 | |
Huang et al., 2017 | retrospective | 22 | |
D. Chen et al., 2018 | na | 68 | |
C.-L. Chen et al., 2018 | I | 3 | |
Z. Wang et al., 2018 | na | 1 | |
C. Li et al., 2019 | na | 34 | |
Y. Zhao et al., 2019 | prospective | 95 | |
L. Zhang et al., 2019 | II | 40 | |
Melanoma | Niu et al., 2011 | na | 2 |
Jinying Zhang et al., 2012 | na | 6 | |
Hong Li et al., 2017 | na | 55 | |
F. Chen et al., 2017 | na | 1 | |
Hong et al., 2016 | na | 4 | |
Multiple myeloma | Laport et al., 2011 | na | 3 |
X. Zhou et al., 2013 | na | 2 | |
Y. Liu et al., 2016 | retrospective | 1 | |
Y. Luo et al., 2016 | I | 2 | |
Introna et al., 2017 | II a | na | |
Myelodysplastic syndrome | B. Yang et al., 2012 | pilot | 5 |
Introna et al., 2007 | I | 2 | |
Introna et al., 2017 | II a | na | |
Narayan et al., 2019 | II | 27 | |
Nasopharyngeal carcinoma | Y. Li et al., 2015 | retrospective | 112 |
C.-L. Chen et al., 2018 | I | 1 | |
J.-J. Zhao et al., 2018 | retrospective | 85 | |
Ovarian cancer | Niu et al., 2011 | na | 1 |
J. Liu et al., 2014 | na | 46 | |
Z. Zhang et al., 2015 | retrospective | 4 | |
C. Zhang et al., 2017 | na | 2 | |
C.-L. Chen et al., 2018 | I | 1 | |
Y. Zhou et al., 2019 | retrospective | 72 | |
Pancreatic cancer | Jinying Zhang et al., 2012 | na | 3 |
M. Wang, Shi, Qi, Tang, & Tian, 2013 | prospective | 28 | |
Chung, Park, Bang, Park, & Song, 2014 | II | 20 | |
Z. Zhang et al., 2015 | retrospective | 1 | |
Z. Wang et al., 2016 | retrospective | 25 | |
N. Jiang et al., 2017 | prospective | 36 | |
C. Li et al., 2019 | na | 2 | |
Prostate cancer | J. Yu et al., 2011 | na | 1 |
Sarcoma | J. Yu et al., 2011 | na | 1 |
Jinying Zhang et al., 2012 | na | 2 | |
F. Chen et al., 2017 | na | 2 | |
Hong et al., 2016 | na | 1 | |
Thyroid cancer | J. Yu et al., 2011 | na | 4 |
Ureter cancer | Jinying Zhang et al., 2012 | na | 1 |
Total | 4551 |